+This project aims to move beyond traditional manual grading systems developed by pathologists toward machine learning–based prognostication models trained on real-world clinical outcomes such as survival, recurrence, and treatment response. Traditional methods, which are designed to replicate the assessments of pathologists, are inherently limited by human-level accuracy. Instead, we propose to discover ML-driven biomarkers that may reveal novel prognostic patterns and potentially exceed expert-level performance.
0 commit comments